4-Bromo-5-methyl-1H-pyrazole-3-carboxamide, 95.0%, 250mg

6-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 250mg

4-(4-Methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde, 98% +(isomers mixture), 5g

4-Chloro-2-cyclopropyl-6-fluoroquinazoline, 97%, 1g

(4-Chloro-1-methyl-1h-pyrazol-3-yl)methanamine, 98%, 250mg

(R)-1-N-Cbz-2-Chloromethyl-pyrrolidine, 97.0%, 1g

(R)-Chroman-3-amine hydrochloride, 95.0%, 250mg

1-Phenyl-2,5,8,11-tetraoxatridecan-13-ol, 98.0%, 25g

1-Phenyl-3-buten-1-ol, 97.0%, 1g

Methyl 4-chloro-3-cyanobenzoate, 95.0%, 5g

1H-PYRROLO[2,3-B]PYRIDINE, 5-BROMO-4-CHLORO-1-(PHENYLSULFONYL)-, 95.0%, 100mg

Balance d'analyse et de précision Série Entris® II Modèles avec réglage interne, non certifiés, 0,001 g, 320 g, BCE323i-1S (W)

1-(2-methoxypyridin-3-yl)methanamine; oxalic acid, 95.0%, 1g